Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | iC9.GD2.CAR.IL-15 T-cells |
Trade Name | |
Synonyms | |
Drug Descriptions |
iC9.GD2.CAR.IL-15 T-cells comprise T-lymphocytes engineered to express a chimeric antigen receptor (CAR) that targets the disialoganglioside GD2 linked to CD28 and CD3zeta domains, as well as IL-15, and inducible caspase-9, which potentially induces cytotoxicity against tumor cells expressing GD2 and inhibits tumor growth (PMID: 30617136). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C158732 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
iC9.GD2.CAR.IL-15 T-cells | iC9.GD2.CAR.IL-15 T-cells | 0 | 2 |